<DOC>
	<DOCNO>NCT00583375</DOCNO>
	<brief_summary>STUDY OBJECTIVES : Demonstrate equivalent clinical radiologic outcomes `` gold standard '' ( ABG ) representative clinical model ( hindfoot ankle fusion ) STUDY HYPOTHESIS : GEM OS™1 equivalent bone graft substitute autologous bone graft application show non-inferiority analysis STUDY RATIONALE : Evaluate fully synthetic growth-factor enhance bone graft substitute facilitate fusion condition injury require bone graft representative clinical fusion model thus opportunity provide equivalent union rate ABG without necessitate additional invasive procedure harvest graft REGULATORY PHASE : Investigational Device Exemption ( IDE ) Premarket Approval ( PMA ) Application bone regeneration system , pivotal phase</brief_summary>
	<brief_title>GEM OS™1 Bone Graft Compared Autologous Bone Graft Foot Ankle Fusions</brief_title>
	<detailed_description />
	<criteria>1 ) Bone defect hindfoot ankle require fusion use open surgical technique supplemental bone graft/substitute , require one follow procedure : Ankle joint fusion Subtalar fusion Calcaneocuboid fusion Talonavicular fusion Triple arthrodesis ( subtalar , talonavicular calcaneocuboid joint ) Double fusion ( talonavicular calcaneocuboid joint ) 1 . Previous fusion surgery propose fusion site . 2 . The patient use chronic medication know affect skeleton ( e.g . glucocorticoid usage &gt; 10mg/day ) . 3 . Pregnant female intend become pregnant study period . 4 . Morbidly obese ( BMI &gt; 45 kg/m2 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>arthritis</keyword>
	<keyword>ankle pain</keyword>
	<keyword>foot pain</keyword>
	<keyword>hindfoot fracture</keyword>
	<keyword>ankle fracture</keyword>
</DOC>